[Biochemical characteristics associated with diabetes mellitus one year after myocardial infarction]. 2014

O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova

OBJECTIVE To evaluate the most informative parameters of adipokine, anti-inflammatory, and prothrombogenic status associated with diabetes mellitus. METHODS The study included 200 patients with myocardial infarction (MI) in whom markers of adipokine status, grelin, anti-inflammatory factors, CRP and plasminogen activator inhibitor were measured by biochemical methods on days 1 and 12 after admission. RESULTS In the period of acute MI, the adipokine status was disturbed, FFA and grelin levels decreased, pro-inflammatory and thrombotic potential increased. Patients who developed diabetes within 1 year after MI were characterized by more pronounced changes of the parameters of interest. CONCLUSIONS Adiponectin, retinol-binding protein, grelin, TNF-α, and plasminogen activator inhibitor are the most informative biochemical parameters associated with diabetes mellitus developing 1 year after MI.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
February 1991, American heart journal,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
August 1983, Vrachebnoe delo,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
June 1993, Revista medica de Chile,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
June 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
December 2007, Heart (British Cardiac Society),
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
October 1984, The American journal of cardiology,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
February 1956, American heart journal,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
April 1983, Journal of the American College of Cardiology,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
October 2003, Journal of human hypertension,
O L Barbarash, and O V Gruzdeva, and O E Akbasheva, and E V Belik, and E G Uchasova, and V N Karetnikova, and T S Fedorova
March 1988, European heart journal,
Copied contents to your clipboard!